Mary Larijani, MD

About Mary Larijani, MD

Titles

Attending Physician

Certifications

Dermatology – American Board of Dermatology

Awards and Honors

2020, Top Doctor, Main Line Today
2016, Stelwagon Competition First Prize Winner, Section on Dermatology of The College of Physicians of Philadelphia
2015, Magna Cum Laude, Sidney Kimmel Medical College of Thomas Jefferson University
2014, Alpha Omega Alpha Honor Medical Society, Junior Induction, Pennsylvania Alpha Chapter
2014, Third Place in Poster Competition, AOA Research Symposium, Sidney Kimmel Medical College at Thomas Jefferson University
2013, American Skin Association’s Medical Student Grant
2013, Hobart Amory Hare Honor Society, Sidney Kimmel Medical College at Thomas Jefferson University
2012, Lavine Scholarship, Thomas Jefferson University
2012, American Dermatological Association Medical Student Fellowship
2011, Graduated with Honors, University of Michigan

Leadership and Memberships

Memberships in Professional Organizations

2016-present, American Academy of Dermatology
2016-present, Society for Pediatric Dermatology
2016-present, Women's Dermatologic Society

Education & training

Medical Degree

MD - Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

Internship

Internal Medicine - Lankenau Medical Center, Wynnewood, PA

Residency

Dermatology - Thomas Jefferson University, Philadelphia, PA
Dermatology - Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA

Fellowship

Dermatology - The Children’s Hospital of Philadelphia, Philadelphia, PA

Team affiliations

 View fewer all team affiliations View all all team affiliations

Publications

Publications

2021

Tamazian S, Oboite M, Larijani M, Oliver B, Milbar H, Jen M, Treat JR.: Toxic erythema of chemotherapy affecting the ears of an infant: A case report. Pediatr Dermatol 38: 512-513, Mar 2021.

Mary Larijani MD, Adam I. Rubin MD, Melinda Jen MD: Recurrent blisters in a 6-year-old girl. Pediatric Dermatology 38(3), May/June 2021.

2018

Nadhan KS, Larijani M, Abbott J, Doyle AM, Linfante AW, Chung CL.: Prevalence and Types of Genital Lesions in Organ Transplant Recipients. JAMA Dermatol 154: 323-329, Mar 2018. PMCID: PMC5885815

Neidig L, Jin A, Larijani M, Chung CL.: Penile basal cell carcinoma in a black kidney transplant recipient. JAAD Case Rep 4: 969-971, Oct 2018. PMCID: PMC6214887

2017

Kemp DM, Pidich A, Larijani M, Jonas R, Lash E, Sato T, Terai M, De Pizzol M, Allegretti M, Igoucheva O, Alexeev V.: Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment. Oncotarget 8: 14428-14442, Feb 2017. PMCID: PMC5362416

2013

Igoucheva, O, Grazzini, M, Pidich, A, Kemp, D M, Larijani, M, Farber, M, Lorton, J, Rodeck, U, Alexeev, V: Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine. Gene Ther 20: 939-48, Sep 2013.

2009

Le S, Finn JP, Larijani ME, Marino MJ, Schaffhauser H.: Detection of low level histamine H3 receptor occupancy by autoradiography. J Neurosci Methods 185: 70-5, Dec 2009.

Abstracts (includes Posters and Scientific Presentations)

2018

Larijani M. Erythema Elevatum Diutinum: Not your average leukocytoclastic vasculitis. Oral presentation: Philadelphia Dermatological Society. Philadelphia, PA. October 2018.

Lectures by Invitation
2018

Larijani M. "Erythema Elevatum Diutinum: Not your average leukocytoclastic vasculitis.", Philadelphia Dermatological Society, Philadelphia, PA. October 2018.

Larijani M. "Racial Differences in Rates of Malignant and Infectious Cutaneous Genital Disease After Solid Organ Transplantation." American Transplant Congress. Seattle, WA. June 2018.

Editorials, Reviews, Chapters
2018

Griffin Jr. TD, Larijani M, Hazan E, Saedi N.: Anatomy of Facial Vasculature/Musculature. Reconstructive Dermatologic Surgery. Shang I Brian Jiang (eds.). Jaypee Brothers Medical Publishers Ltd. 2018.

Patient experience rating

(based on 222 submissions)
  • Clear Explanation
    4.8 of 5
  • Showed Concern
    4.9 of 5
  • Included in decisions
    4.8 of 5
  • Would recommend
    4.8 of 5
  • Discussion of Proposed Treatment
    4.8 of 5
Learn about the patient experience rating system

Comments

  • Dr. Larijani had excellent bedside manner! She explained the skin condition in simple terms so my 9 year old understood. Very personable.
    5 of 5
    May 25, 2024

  • Great ! Explained everything very well and great bedside manner.
    5 of 5
    Apr 16, 2024

  • After diagnosing my daughters illness, treatment of it began immediately after discussing what it was, our options to treat, what to expect and our desire to move forward with the Dr.'s suggestions.
    5 of 5
    Mar 14, 2024

  • We went there for a follow up visit for exema on his and we ended up getting treatments for his acne as well
    5 of 5
    Mar 14, 2024

  • So happy with the dr I had and the staff that helped up.
    5 of 5
    Feb 16, 2024

  • My questions were answered thoroughly and follow up for next steps well done.
    5 of 5
    Jan 11, 2024

  • Our dr was very informative and gentle. She was great!
    5 of 5
    Jan 10, 2024

  • Excellent and kind Doctor and Staff.
    5 of 5
    Dec 06, 2023

  • Doctor was very pleasant and addressed all of our concerns
    5 of 5
    Nov 30, 2023

  • Our experience was great! Dr. Laranjani and her team were fantastic, engaged with my 11 year old, spoke to him and explained things to me.
    5 of 5
    Aug 25, 2023

  • Dr. Mary E Larijani is a great doctor. She answers all of my questions thoroughly.
    5 of 5
    May 19, 2023

  • Dr. Larijani is an absolute delight. She is warm, thoughtful, and beyond knowledgeable. I am so grateful for her expertise and I am truly appreciative that my son was able to benefit from her care. I would highly recommend her to anyone!!
    5 of 5
    Feb 28, 2023
View more comments View less comments

About the Patient Experience Rating System

The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient’s protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.